Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Leukemia, Myeloid, Chronic-Phase 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 8 Glioblastoma 8 Polycythemia Vera 7 Meningioma 7 Leukemia, Myeloid, Acute 7 Head and Neck Neoplasms 7 Gliosarcoma 6 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2 Treatment-Refractory Solid Tumors 1 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombosis 1 Thrombocytosis 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Specimen Handling 15 Nivolumab 15 Cetuximab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 130-nm albumin-bound paclitaxel 10 Platinum 9 Bevacizumab 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00468169 2019-10-09

EPIC

University of Chicago

Phase 2 Completed

110 enrolled 14 charts

Carcinoma, Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡